CCAP CCAP
Company Profile ↓Company Overview
CCAP (CCAP) is a publicly traded company listed on with a market capitalization of $417.01M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 6.2.
Recent Developments
- Trailing 12 Months Year-on-year growth — earnings -53.1%.
- 5-Year Trend Long-term compounding — profit CAGR -8.8%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | -8.79% |
| 1 Year: | -53.14% |
Stock Price Performance
| 1 Year: | -9.19% |
| 6 Months: | -14.20% |
| 3 Months: | -16.21% |
| 1 Month: | +2.17% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)54.64 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -8.8% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -12.58M | -14.09M | -10.98M | -13.38M | -21.59M | -25.83M | -26.08M | -26.68M | -26.82M | -27.44M | -25.01M | -25.70M | -24.14M | -21.87M |
| Net Income | 16.68M | 16.21M | -890.00K | -2.38M | 7.78M | 22.58M | 22.62M | 28.00M | 20.39M | 15.27M | 3.90M | 15.01M | 7.10M | -15.51M |
| Diluted EPS | 0.45 | 0.39 | 0.50 | 0.52 | 0.54 | 0.56 | 0.59 | 0.63 | 0.59 | 0.64 | 0.45 | 0.46 | 0.46 | 0.42 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Income | -26.69M | -44.11M | -56.83M | -100.29M | -106.78M | -98.69M |
| Net Income | 54.67M | 83.63M | 15.54M | 83.84M | 73.65M | 34.51M |
| Diluted EPS | 1.80 | 1.67 | 1.93 | 2.30 | 2.40 | 1.81 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.32B | 1.30B | 1.63B | 1.66B | 1.62B |
| Current Assets | - | - | - | - | - | - | - |
| Cash & Equivalents | - | 1.75M | 10.07M | 6.40M | 7.78M | 10.13M | 5.04M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | 9.95M | 14.25M | 12.17M | 17.35M |
| Total Liabilities | - | - | 665.52M | 690.34M | 884.78M | 915.64M | 916.10M |
| Current Liabilities | - | - | - | - | - | - | - |
| Long Term Debt | - | - | 631.04M | - | - | - | - |
| Total Debt | - | - | - | 654.46M | 844.78M | 875.84M | 873.76M |
| Total Equity | 406.92M | 560.00M | 652.28M | 612.54M | 742.59M | 740.64M | 706.04M |
| Shares Outstanding | - | - | - | 30.89M | 37.06M | 37.06M | 36.97M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -61.80M | -157.65M | 27.95M | 92.30M | 58.91M | 74.72M |
| Financing Cash Flow | 63.22M | 166.32M | -34.41M | -84.99M | -43.47M | -82.54M |
| Share Buybacks | 2.21M | - | - | - | - | 1.33M |
| Dividends Paid | 42.63M | 47.73M | 55.29M | 64.55M | 75.23M | 67.81M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 9.8% | 12.8% | 2.5% | 11.3% | 9.9% | 4.9% |
| ROCE % | - | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CCAP
CORESTATE Capital Holding SA Actuals & Estimates (XETR:CCAP) - TradingView
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOX1d2LTlwT1l4VzhYOWlzc2NSRFlqRWk2bUVwLTZmUWd5QUFWQXhiMHdMaVppTk1VZXhnNjN1OWpyamxrZ2FyMEkyQ084VWRaaTZhOGRXT2dXN0NJWXF6ZjR1OWVCMERkMkF1SGQzQkdIVkg0d3YyTERWaVdiWnhTRHo2SQ?oc=5" targe…
Crescent Capital BDC (CCAP) Tops Q1 Earnings Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOc19BMjlfWE5wSXRiY285Mld2V0t6N05Mcm1XX244R2IxWXhJdGU2T2p6UmU3OWtWUUR6dWdHeG0wMGV1WnVmbzM0VzJFaWdvVnFfUzZBVTRveUxBbVp6RzRHRjdTelZtS0xJWXVpS3VDZnBlZE5aMjFObm1aVnJEa0s2ZFE2QWdsaVlNaH…
CCAP|Crescent Capital BDC Inc|Price:10.930|Chg%:+0.080 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE80X3VhMzhXZHozQXBvbzBMRGRVcDRPTmRkWVFESFZETTA3ejNCZU4wUXlPazV3bGxlMUtZSzlWNkx6cHAxOHd1Ymt5a1N1STNMYzVKdThSSWhNOVVFTDZ1emZTY3dQWi1VV25XM3FR?oc=5" target="_blank">CCAP|Crescent Capit…
BLAC PE Ratio & Valuation, Is BLAC Overvalued - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTFBVN2gzZXFtQTRyTnJPWFA0WnFGVmRUQjNLcGpqd3hxckk4WVRhb0x5c0RGbTRGODBVb1l4eDlvSVo4MFFPSGFpcDdQXy02a1lobUtzR2FTUFRXQQ?oc=5" target="_blank">BLAC PE Ratio & Valuation, Is BLAC Overvalued…
Crescent Capital BDC, Inc. Schedules Earnings Release and - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMitAJBVV95cUxPR29GaVkyZFhDUm92NElGcEt2YXdhQkNLbWNnSVNJcDdKR2hibmpYLXJ5V0M5WjN5aGh5N3QzbXZZbUJEa0NHVEJsWlJfMFQwMWdZZHN4Q0FMQ0RuRE0taVNZUzBCN3NUZGE2elFzZ3VyekFScjdMMFVabEh6bUxvQnEyR1EzSkZ2cUg2ZD…
(CCAP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQYjZMRUtDaVBNLUNXYTg3dWFMZ3RydTJ4VkhNVTlsZURDMFRhQXYtWFJ5bjQwUlk1U05YZVlWcGJSU1lNSmEwaWplTVB4Rm4xbFlkNjFsMFVHanlMbFA5X1BGeXlqeWEwblBlWnBsb1NaS055Q29fZy05a3hqcjVIVmJ1SEVOWTlyUFVoZX…
CCAP — Frequently Asked Questions
What is the current share price of CCAP?
As of 2026-08-05 17:25 PDT, CCAP trades at $11.28 on NASDAQ/NYSE. Its 52-week range is $10.63 to $14.06.
What is the market capitalisation of CCAP?
CCAP has a market capitalisation of $417.01M on NASDAQ/NYSE.
What is the P/E ratio of CCAP?
CCAP trades at a trailing price-to-earnings (P/E) ratio of 6.23. Its price-to-book (P/B) ratio is 0.59.
What is the return on equity (ROE) of CCAP?
CCAP has a return on equity (ROE) of 4.89%.
Is CCAP a good stock to buy?
This page provides a data-driven analysis of CCAP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.